PATHFINDER Study for Adults with Tricuspid Valve Regurgitation
Protocol: STUDY00010292
Full Title
Transcatheter Tricuspid Valve Replacement using the Medtronic Intrepid (TM) TTVR System in patients with Severe Symptomatic Tricuspid Regurgitation (PATHFINDER)
Description
Doctors from UB are looking for adults living with tricuspid regurgitation (TR) for a clinical trial. TR happens when there is a leaking heart valve. This occurs when the heart’s tricuspid valve does not close as it should. The blood flows backwards instead of forward with each heartbeat which may cause people to feel tired. They may also have swelling in their legs and stomach and might be unable to do as much because their heart is not working properly.

The purpose of this study is to evaluate how safe and effective a new system is treating patients with severe TR. Participants may be in this study for about 10 years. They will have the procedure and then follow-up visits at 30 days, 3 months, 6 months, and annually for 10 years. During the follow-up visits they will complete physical exams, blood tests, and other tests and surveys.

Participants will be paid $75 for each in-person study visit.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
-Adults 18 years or older
-Have been diagnosed with tricuspid valve regurgitation
Age Group: Adults
Principal Investigator: VIJAY IYER
ClinicalTrials.gov: Open Study
Contact(s)
DAWN HOLLER
dlh68@buffalo.edu
+1 716-829-6115

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions